Email ID
Sign me in automatically next time
Nexavar case may spawn more India compulsory licensing activity in oncology/HIV areas

India's recent decision granting a compulsory licence for Bayer's anticancer Nexavar (sorafenib tosylate) to Natco Pharma may theoretically open the flood gates to several more...
16 March 2012
Anju Ghangurde

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36